IntroductionHIV type 1 (HIV-1) infection typically involves a progressive loss of blood CD4 ϩ T lymphocytes, associated with functional T-cell abnormalities and immunodeficiency. There may be several reasons for the decrease in CD4 ϩ T-cell counts, including direct and indirect virus-mediated cell destruction and defective homeostasis. 1,2 The half-life of peripheral blood T cells, which is approximately 82 days in healthy individuals, is more than 50 days shorter in HIV-infected patients 3 and T-cell numbers appear to be maintained at high levels principally by an increase in the production of CD8 ϩ T cells.Different mechanisms have been proposed for explaining defective production of T lymphocytes, including deregulated thymus activity, infection, and depletion of immature thymocytes expressing CD4 and alteration of early progenitors including at the level of bone marrow (BM) CD34 ϩ precursors. To our knowledge, this last point has never been clearly addressed and was therefore the purpose of our work.Defective de novo production of T lymphocytes by the thymus may make a significant contribution to CD4 ϩ T-cell lymphopenia. In HIV infection, a low proportion of recent thymic emigrants, with episomal DNA formed by rearrangement of the T-cell receptor genes (TREC), 4 is correlated with disease progression, although the value of quantitative TREC measurement in HIV-seropositive patients remains unclear. 5,6 Highly active antiretroviral therapy (HAART) helps to increase the number of CD4 ϩ T cells in the periphery, probably due to both the expansion and redistribution of cell populations present in lymphoid tissues and the de novo generation of T lymphocytes by the thymus. 7-9 T-cell counts are restored to high levels in a biphasic manner following the initiation of HAART. There is an initial rapid increase in the numbers of CD4 ϩ and CD8 ϩ T cells of the memory phenotype (CD45RO ϩ ), and then the proportion of naive T cells (CD45RA ϩ CD62L ϩ ) increases. 7 Changes in thymus volume and an increase in TREC levels in the periphery 10 also provide evidence that successful HAART increases thymus activity. 11 However, CD4 ϩ T-cell counts remain below normal values in treated patients, suggesting that thymic production is not completely restored and is not necessarily associated with an increase in lymphocyte half-life 3 and the complete restoration of efficient antiviral immunity.Changes in thymus function in patients infected with HIV-1 result directly from degeneration of the stroma, infection of immature thymocytes, and dysregulation of thymocyte/stromal cell interactions. [12][13][14] Decreases in the pool of early progenitor stem cells, including the most primitive CD34 ϩ hematopoietic BM cells, may also limit T-cell regeneration. 15 18 and the antibiotics commonly used in patients with AIDS may all affect the production of blood cells. However, although hematopoietic cells do not seem to undergo direct infection with HIV, they may be directly damaged due to the inhibitory effect of HIV-related proteins 19 or proi...